Alnylam Pharmaceuticals is a biopharmaceutical company and pioneer in RNA interference (RNAi) therapeutics, developing medicines designed to silence disease-causing genes.
NewLink Genetics is a biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer.